Logo image
Back
Monoclonal antibodies with cytotoxic reactivities against human gliomas
Journal article   Peer reviewed

Monoclonal antibodies with cytotoxic reactivities against human gliomas

Anil Nanda, Boleslaw Liwnicz, Barbara F. Atkinson, Ben-Ami Sela, Hiroshi Takahashi, Paul H. Belser, Perry Black, Hilary Koprowski and Dorothee Herlyn
Journal of neurosurgery, v 71(6), pp 892-897
Dec 1989
DOI: https://doi.org/10.3171/jns.1989.71.6.0892
PMID: 2585082
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

✓ Monoclonal antibodies (MAb's) reactive with human malignant glioma cells were derived from mice inoculated with cells from fresh glioma tissue. Seven MAb's were selected for study based on their high-level binding in immunoperoxidase and immunofluorescence assay to most of the glioma tissues derived from various patients and based on the absence of binding to normal bone marrow cells. Four of the seven MAb's did not bind to any of the four normal brain tissues tested, whereas three MAb's bound to one or two of these tissues. Two MAb's bound to the surfaces of cultured glioma cells in radioimmunoassay. One of these MAb's (AS-AY1, immunoglobulin (Ig)G 1 ) lysed cultured glioma cells with human lymphocytes or murine macrophages as effector cells; the other MAb (AS-AY2, IgM) was reactive in complement-dependent cytotoxicity assay. These two MAb's therefore seem especially promising reagents in approaches to immunotherapy of human malignant glioma.

Metrics

17 Record Views
6 citations in Web of Science
6 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Clinical Neurology
Surgery
Logo image